Reaction
Non-Cirrhotic Portal Hypertension reporting signals
As of the last recalculation, Non-Cirrhotic Portal Hypertension appears in 359 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is OXALIPLATIN (PRR 187.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Oxaliplatin | 144 | 187.2 | 187.6 |
| Ado-Trastuzumab Emtansine | 11 | 78.0 | 78.1 |
| Fluorouracil Cream, 0.5% | 77 | 74.2 | 74.3 |
| Fluorouracil | 77 | 73.2 | 73.3 |
| Leucovorin Calcium | 21 | 67.6 | 67.7 |
| Efavirenz | 12 | 64.5 | 64.6 |
| Tenofovir Disoproxil Fumarate Tablets | 8 | 54.9 | 55.0 |
| Capecitabine | 52 | 38.4 | 38.4 |
| Lamivudine Oral | 14 | 33.3 | 33.4 |
| Fam-Trastuzumab Deruxtecan-Nxki | 3 | 17.4 | 17.4 |